BOLTON SECURITIES CORPORATION’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
BOLTON SECURITIES CORPORATION's DNA Position: Q1 2026 in Review
BOLTON SECURITIES CORPORATION opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 1,484 shares worth $9.1K. The stake represents ﹤0.01% of the portfolio and ranks #1643 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in DNA as recently as Q3 2025.
BOLTON SECURITIES CORPORATION first reported a position in DNA in Q1 2025 and has held it in 3 quarters since. The position peaked at $21.6K in Q3 2025. 177 funds tracked by Wall St. Rank hold DNA as of Q1 2026.
- BOLTON SECURITIES CORPORATION held 1,484 shares of Ginkgo Bioworks worth $9.1K as of Q1 2026.
- Ginkgo Bioworks was a new BOLTON SECURITIES CORPORATION position in Q1 2026.
- Ginkgo Bioworks made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q1 2026, its #1643 holding.
- BOLTON SECURITIES CORPORATION first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 3 quarters since.
- BOLTON SECURITIES CORPORATION's Ginkgo Bioworks position peaked at $21.6K in Q3 2025.
- 177 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.
Based on BOLTON SECURITIES CORPORATION's 13F filing for Q1 2026, filed 12 Nov 2026.